Bovie Medical Co. (BVX) Trading Down 4.2%
Shares of Bovie Medical Co. (NYSE:BVX) were down 4.2% during mid-day trading on Tuesday . The company traded as low as $4.26 and last traded at $4.31, with a volume of 84,659 shares traded. The stock had previously closed at $4.50.
A number of analysts have recently issued reports on BVX shares. JMP Securities reaffirmed an “outperform” rating and set a $5.00 price objective on shares of Bovie Medical in a report on Wednesday, August 3rd. Zacks Investment Research raised shares of Bovie Medical from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th.
The firm’s market cap is $117.13 million. The company has a 50-day moving average price of $2.75 and a 200 day moving average price of $2.03.
In other Bovie Medical news, insider John J. Mccarthy III bought 90,750 shares of Bovie Medical stock in a transaction on Wednesday, August 17th. The stock was acquired at an average cost of $3.30 per share, with a total value of $299,475.00. Following the completion of the acquisition, the insider now owns 115,750 shares in the company, valued at $381,975. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.